Markus Christian Gershater
Technik-/Wissenschafts-/F&E-Leiter bei Synthace Ltd.
Aktive Positionen von Markus Christian Gershater
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Synthace Ltd.
 Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Direktor/Vorstandsmitglied | 08.04.2019 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 | - | |
| Gründer | 01.01.2011 | - |
Karriereverlauf von Markus Christian Gershater
Ehemalige bekannte Positionen von Markus Christian Gershater
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Novacta Biosystems Ltd.
 Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
| University College London | Corporate Officer/Principal | - | - |
Ausbildung von Markus Christian Gershater
| University of Durham | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Consumer Services | 3 |
| Technology Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Synthace Ltd.
Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Technology Services |
Novacta Biosystems Ltd.
Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Health Technology |
